Bioorganic and Medicinal Chemistry Letters, volume 95, pages 129471

Synthesis and anti-tumor activities in human leukemia-derived cells of polyenylpyrroles with a methyl group at the conjugated polyene terminus

Tomoya Higashi 1
Chihiro Yoshida 1
Yoshifumi Hachiro 1
Chihiro Nakata 2, 3
Azusa Takechi 3, 4
Takuya Yagi 2, 3
Kazuya MIYASHITA 3, 5
Nobuo Kitada 1
Rika Obata 6
Takashi Hirano 6
Takahiko Hara 2, 3, 4
Shojiro MAKI 1
Show full list: 12 authors
Publication typeJournal Article
Publication date2023-10-01
scimago Q2
wos Q2
SJR0.508
CiteScore5.7
Impact factor2.5
ISSN0960894X, 14643405
Organic Chemistry
Drug Discovery
Biochemistry
Molecular Biology
Pharmaceutical Science
Clinical Biochemistry
Molecular Medicine
Abstract
To develop novel drugs for treating T-cell acute lymphoblastic leukemia (T-ALL) and acute myeloid leukemia (AML) which are highly malignant hematological tumors, a series of analogs having a polyenylpyrrole structure of natural compounds (rumbrin and auxarconjugatin B) were synthesized and investigated their structure-activity relationships (SAR) of in vitro anti-T-ALL and anti-AML activities. We obtained three findings: (1) introduction of a methyl group at the conjugated polyene terminus enhanced anti-T-ALL activity, (2) analogs with a 3-chloropyrrole moiety had even higher selectivity for T-ALL cells, and (3) some analogs were effective against AML-derived cells. Among the studied compounds, 3-chloro-2-(8-ethoxycarbonylnona-1,3,5,7-tetraenyl) pyrrole 4e was the most promising candidate of T-ALL- and AML-treating drug. This study provides useful structural information for designing novel drugs treating T-ALL and AML.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Share
Cite this
GOST | RIS | BibTex
Found error?